TNF and parasitic infectious disease: A different mAb against CD25 was shown to reduce parasitemia and to increase effector memory T cells and IFN-γ/TNF-α-secreting cells in mice when administered during the acute phase, while when administered at the beginning of the chronic phase it was shown to reduce the local inflammatory process in the heart.